126 related articles for article (PubMed ID: 11752445)
1. Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus.
Malstrom S; Tili E; Kappes D; Ceci JD; Tsichlis PN
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14967-72. PubMed ID: 11752445
[TBL] [Abstract][Full Text] [Related]
2. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia.
Rodriguez-Puebla ML; LaCava M; Miliani De Marval PL; Jorcano JL; Richie ER; Conti CJ
Am J Pathol; 2000 Sep; 157(3):1039-50. PubMed ID: 10980142
[TBL] [Abstract][Full Text] [Related]
4. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.
Pirkmaier A; Dow R; Ganiatsas S; Waring P; Warren K; Thompson A; Hendley J; Germain D
Oncogene; 2003 Jul; 22(28):4425-33. PubMed ID: 12853979
[TBL] [Abstract][Full Text] [Related]
5. p27 deficiency cooperates with Bcl-2 but not Bax to promote T-cell lymphoma.
Cheng N; van de Wetering CI; Knudson CM
PLoS One; 2008 Apr; 3(4):e1911. PubMed ID: 18382684
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
[TBL] [Abstract][Full Text] [Related]
8. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D3 and megakaryocyte development: exploration of a transgenic phenotype.
Zimmet JM; Toselli P; Ravid K
Stem Cells; 1998; 16 Suppl 2():97-106. PubMed ID: 11012182
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids delay age-associated thymic involution through directly affecting the thymocytes.
Pazirandeh A; Jondal M; Okret S
Endocrinology; 2004 May; 145(5):2392-401. PubMed ID: 14736739
[TBL] [Abstract][Full Text] [Related]
11. Mouse development and cell proliferation in the absence of D-cyclins.
Kozar K; Ciemerych MA; Rebel VI; Shigematsu H; Zagozdzon A; Sicinska E; Geng Y; Yu Q; Bhattacharya S; Bronson RT; Akashi K; Sicinski P
Cell; 2004 Aug; 118(4):477-91. PubMed ID: 15315760
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
[TBL] [Abstract][Full Text] [Related]
13. Cdc2-cyclin E complexes regulate the G1/S phase transition.
Aleem E; Kiyokawa H; Kaldis P
Nat Cell Biol; 2005 Aug; 7(8):831-6. PubMed ID: 16007079
[TBL] [Abstract][Full Text] [Related]
14. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
Ando K; Griffin JD
Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
16. Enhanced apoptosis in the thymus of transgenic mice expressing constitutively activated forms of human Rac2GTPase.
Lorès P; Morin L; Luna R; Gacon G
Oncogene; 1997 Jul; 15(5):601-5. PubMed ID: 9247314
[TBL] [Abstract][Full Text] [Related]
17. 4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1.
Lee HW; Nam KO; Park SJ; Kwon BS
Eur J Immunol; 2003 Aug; 33(8):2133-41. PubMed ID: 12884287
[TBL] [Abstract][Full Text] [Related]
18. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
19. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma.
Sasaki E; Yatabe Y; Hashimoto M; Yamashita Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Pathol Int; 2007 Feb; 57(2):53-9. PubMed ID: 17300668
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific expression and activation of N-methylpurine-DNA glycosylase in thymic carcinomas of transgenic mice expressing the SV40 large T-antigen gene.
Kim NK; Lee SH; Cha KY; Seo JS
Mol Cells; 1998 Aug; 8(4):383-7. PubMed ID: 9749523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
